Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Southwest Oncology Group (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

carboplatin (1)

paclitaxel (1)

pembrolizumab (1)

ramucirumab (1)

Study Documents

Intervention Type

biological (2)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (2)

unresectable thymic carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Thymoma, Thymic Cancer Trial in Houston (Pembrolizumab)

Recruiting

Stage III Thymoma AJCC v8
+6 more

Pembrolizumab

Houston, Texas

M D Anderson Cancer Center

Nov 11, 2022

Locally Advanced Thymic Carcinoma, Metastatic Thymic Carcinoma, Recurrent Thymic Carcinoma Trial in United States (Carboplatin,

Recruiting

Locally Advanced Thymic Carcinoma
+3 more

Carboplatin
+2 more

Anchorage, Alaska
+253 more

Jan 6, 2022